Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse

Genesis (United States)

Volumn 39, Issue 3, 2004, Pages 167-172

  Schuler, Michael ^a   Dierich, Andrée ^a,b   Chambon, Pierre ^a,b   Metzger, Daniel ^a,b  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSTITUT CLINIQUE DE LA SOURIS   (France)

Author keywords

Cre ERT2 recominase; Cre LoxP technology; Liver; Serum albumin; Tamoxifen

Indexed keywords

CRE RECOMBINASE; HYBRID PROTEIN; SERUM ALBUMIN; TAMOXIFEN;

3' UNTRANSLATED REGION; ALLELE; ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE FUNCTION; GENETIC RECOMBINATION; INTERNAL RIBOSOME ENTRY SITE; LIVER CELL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SOMATIC MUTATION; WILD TYPE;

ANIMALIA;

EID: 4043062056     PISSN: 1526954X     EISSN: None     Source Type: Journal    
DOI: 10.1002/gene.20039     Document Type: Article

References (30)

1. Akiyama TE, Gonzalez FJ. 2003. Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochim Biophys Acta 1619:223-234.
2. Arrese M, Trauner M. 2003. Molecular aspects of bile formation and cholestasis. Trends Mol Med 9:558-564.
3. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch J-L, Chambon P, Metzger D. 1997. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA 94: 14559-14563.
4. Cammas F, Mark M, Dolle P, Dierich A, Chambon P, Losson R. 2000. Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development. Development 127: 2955-2963.
5. Chapellier B, Mark M, Garnier JM, LeMeur M, Chambon P, Ghyselinck NB. 2002. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor alpha (RARalpha) gene. genesis 32:87-90.
6. De Feo P, Lucidi P. 2002. Liver protein synthesis in physiology and in disease states. Curr Opin Clin Nutr Metab Care 5:47-50.
7. Dierich A, Dollé P. 1997. Gene targeting in embryonic stem cells. In: Klug S, Thiel R, editors. Methods in developmental toxicology and biology. London: Blackwell Sciences. p 111-123.
8. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. 1996. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 93:10887-10890.
9. Feil R, Wagner D, Metzger D, Chambon P. 1997. Regulation of Cre recombinase activity by mutated oestrogen receptor ligand-binding domains. Biochem Biophys Res Commun 237:752-757.
10. Foufelle F, Ferre P. 2002. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 366:377-391.
11. Imai T, Chambon P, Metzger D. 2000. Inducible site-specific somatic mutagenesis in mouse hepatocytes. genesis 26:147-148.
12. Indra AK, Warot X, Brocard J, Xiao JM, Chambon P, Metzger D. 1999. Temporally controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and CreERT2 recombinases. Nucl Acids Res 27:4324-4327.
13. Kellendonk C, Tronche F, Casanova E, Anlag K, Opherk C, Schutz G. 1999. Inducible site-specific recombination in the brain. J Mol Biol 285:175-182.
14. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche F. 2000. Hepatocyte-specific expression of Cre recombinase. genesis 26:151-153.
15. Kim DG, Kang HM, Jang SK, Shin HS. 1992. Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus. Mol Cell Biol 12:3636-3643.
16. Mascrez B, Mark M, Dierich A, Ghyselinck NB, Kastner P, Chambon P. 1998. The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 125:4691-4707.
17. Metzger D, Chambon P. 2001. Site- and time-specific gene targeting in the mouse. Methods 24:71-80.
18. Metzger D, Indra AK, Li M, Chapellier B, Calleja C, Ghyselinck NB, Chambon P. 2003. Targeted conditional somatic mutagenesis in the mouse: temporally controlled knock out of retinoid receptors in epidermal keratinocytes. Methods Enzymol 364:379-408.
19. Metzger D, Li M, Chambon P. 2004. Targeted somatic mutagenesis in the mouse epidermis. Epidermal cells: methods and protocols Methods in Molecular Biology. Humana Press Inc., USA (in press).
20. Nahon JL, Tratner I, Poliard A, Presse F, Poiret M, Gal A, Sala-Trepat JM, Legres L, Feldmann G, Bernuau D. 1988. Albumin and alpha-fetoprotein gene expression in various nonhepatic rat tissues. J Biol Chem 263:11436-11442.
21. Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsky IN, Agol VI, Hellen CU. 2001. Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci USA 98:7029-7036.
22. Postic C, Magnuson MA. 2000. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. genesis 26:149-150.
23. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
24. Saxena R, Zucker SD, Crawford JM. 2002. Anatomy and physiology of the liver. In: Zakim D, Boyer TD, editors. Hepatology (a textbook of liver disease). Philadelphia: Saunders. p 3-30.
25. Schaft J, Ashery-Padan R, van der Hoeven F, Gruss P, Stewart AF. 2001. Efficient FLP recombination in mouse ES cells and oocytes. genesis 31:6-10.
26. Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF. 1998. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 26:1427-1432.
27. Tannour-Louet M, Porteu A, Vaulont S, Kahn A, Vasseur-Cognet M. 2002. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver. Hepatology 35:1072-1081.
28. Weber P, Metzger D, Chambon P. 2001. Temporally controlled targeted somatic mutagenesis in the mouse brain. Eur J Neurosci 14:1777-1783.
29. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329.
30. Zhang Y, Buchholz F, Muyrers JP, Stewart AF. 1998. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20:123-128.